Rodríguez MK, Martínez AA, Gutiérrez RÁ, Flores SRM

Language: Spanish
References: 21
Page: 1-15
PDF size: 517.55 Kb.

ABSTRACT

Introduction: Infertility affects to 15% of the couples in childbearing age, and approximately 4-8% of them will need high-tech assisted reproduction techniques. With the participation of women in work life and the subsequent delay of maternity, it is possible the increase of infertility. Anti-Müllerian in women is produced by granular cells. These cells control the recruitment of follicles, their growth and prevent follicles exhaustion; therefore, it represents an important tool in the protocols of ovulation induction.
Objective: Assess the levels of anti-Müllerian hormone as a marker in the ovarian response in patients treated with in vitro fertilization.
Methods: It was conducted a descriptive, observational and cross-sectional study in the consultation of Assisted Reproduction in “Hermanos Ameijeiras” Surgical Clinical Hospital, in the period April, 2017 - April, 2019. The sample was formed by 137 women who attended to this consultation. It was used descriptive and inferential statistics.
Results: Average age of the patients was 33,1 ± 7,4 years old. There was predominance of normal serum concentration of anti-Müllerian hormone in women among 31-35 years old (26,3%), FSH normal level in (39,4%), normal recount of antral follicles (24,1%), good oocyte quality (39,4%), and good embryonic quality (36,5%).
Conclusions: The serum level of the anti-Müllerian hormone was significantly associated to age, the follicle-stimulating hormone, the recount of antral follicles, and the oocyte and embryonic quality.

REFERENCES

1. Llamos SH. Endocrinología en ginecología. La Habana: Ecimed; 2006.

2. Adashi SE. Fisiología y Patología del eje Reproductor Femenino. En: M Henry, M Kronenberg. Williams Tratado de Endocrinología. Madrid: Elsevier; 2017. p. 590-664.

3. La Marca A, Stabile G, Artenisio AC, Volpe A. Serum anti-Müllerian hormone throughout the human menstrual cycle. Human Reprod. 2006;21:3103-7.

4. Broekmans FJ. Revisión sistemática de pruebas predictoras de reserva ovárica y FIV. Actualización en Reproducción Humana. 2006;685-718.

5. Kissell KA, Danaher MR, Schisterman EF, Wactawski J, Ahrens KA, Schliep K, et al. Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women. Hum Reprod. 2014;29:1764-72.

6. Zargar M. Najafian M, Zamanpour Z. Relationship between follicular fluid and serum anti-Mullerian hormone levels and pregnancy rate in ART cycles. Perinatol Reprod Hum [Internet]. 2018 [citado 12 mayo 2019];32(1):3-8. Disponible en: Disponible en: https://www.elsevier.es/es-revista-perinatologia-reproduccion-humana-144-articulo-relationship-between-follicular-fluid-serum-S0187533718300062

7. De Vet A, Laven JS, Jong FH, Themmen AP, Fauser BC. Anti-mullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77:357-62.

8. Sowers MR, Eyvazzadeh AD, McConnell D, Yosef M, Jannausch ML, Zhang D, et al. Anti-müllerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab. 2008;93:3478-83.

9. Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER, Broekmans FJ. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab. 2006;91:4057-63.

10. Centeno I. Infertilidad y del síndrome de ovario poliquístico. Rev Obstet Ginecol Venez [Internet]. 2016 [citado 19 mayo 2019];76(1). Disponible en: Disponible en: http://ve.scielo.org/scielo.php?script=sci_arttext HYPERLINK

11. Torres AP, Torres JM. Climaterio y menopausia. Rev Fac Med UNAM [Internet]. 2018 [citado 14 dic 2019];61(2):51-8. Disponible en: Disponible en: https://www.medigraphic.com/pdfs/facmed/un-2018/un182j.pdf

12. Mensoza J, Kably A, Carballo E, Roque AM, Benitez KL. Correlación entre las concentraciones séricas de hormona antimülleriana y la edad de la mujer con la tasa de recuperación ovular y embarazo. Ginecol Obstet Mex[Internet]. 2019 [citado 19 jul 2019];87(8):535-42. Disponible en: Disponible en: https://www.medigraphic.com/pdfs/ginobsmex/gom-2019/gom198g.pdf

13. Franchin R, Schonauer LM, Righini C, Guibourdenche J, Frydman R, Taieb J. Serum anti-mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod. 2003;18:323-7.

14. Lekamge DN, Barry M, Kolo M, Lane M, Gilchrist RB, Tremellen KP. Anti-mullerian hormone as a predictor of IVF outcome. Reprod Biomed Online. 2007;14(5):602-10.

15. Unger S, Beraja H. Hormona antimülleriana. Reserva ovárica y reserva testicular. Premios Biología - Curso Samer. 2010;25 (3):137-53.

16. Scheffer GJ, Broekmans FJ, Looman CW, Blankenstein M, Fauser BC, teJong FH, et al. The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod. 2003;18:700-64.

17. Dolleman M, Verschuren WM, Eijkemans MJ, Dollé ME, Jansen EH, Broekmans FJ, et al. Reproductive and lifestyle determinants of anti-Mullerian hormone in a large population based study. J Clin Endocrinol Metab. 2013;98:2106-15.

18. Cano N, Genesio K, Nievas MT, Battello N, Anduaga I, Avendaño C, et al. La hormona antimülleriana, predictora de respuesta ovárica y embarazo en tratamientos de reproducción asistida de alta complejidad. 2015. Disponible en: https://www.cobico.com.ar

19. Lehmann P, Vélez MP, Saumet J, Lapensée L, Jamal W, Bissonnette F, et al. Anti-Müllerian hormone (AMH): a reliable biomarker of oocyte quality in IVF. J Assist Reprod Genet. 2014;31:493-8.

20. Guerif F, Lemseffer M, Couet M, Gervereau O, Ract V, Royère D. Serum antimüllerian hormone is not predictive of oocyte quality in vitro fertilization. Ann Endocrinol (Paris). 2009;70:230-4.

21. Godoy Morales HS, Ulloa-Aguirre A, Falcón Martínez JC, Marsai Martínez EE, Rivas López R, García-Lascurain LC. Hormona antimülleriana como marcador de respuesta ovárica en fertilización in vitro. Ginecol Obstet Mex. 2012;80:1-20.